BEAT: Kewajiban jangka cendhak perusahaan HeartBeam Inc

HeartBeam, Inc. (BEAT) focuses its expert guidance on the implementation of remote heart monitoring systems. Fluctuations in short-term debt demonstrate the financial burden, where 0.00 shows the value of this parameter. The company's technological breakthrough lies in 3D-ECG and AI-driven myocardial infarction diagnostics. However, dependence on external capital and regulatory delays create serious risks for the sustainability of the business model.

This indicator measures the total liabilities of HeartBeam, Inc. (BEAT) with maturities of up to one year, reflecting current liquidity and the business's reliance on short-term borrowed capital. By analyzing short-term liabilities, an investor can filter out random market volatility, which, combined with the humanitarian status of its cardiology developments and a focus on the US market, minimizes the risks of a sudden asset drawdown.